Latest Market Integration News

Page 10 of 27
DroneShield Limited has clarified the recent sharp decline in its share price, attributing the market movement to disclosed director share disposals rather than any undisclosed material information.
Sophie Babbage
Sophie Babbage
13 Nov 2025
Resolution Minerals has clarified its compliance with ASX disclosure rules following a $2 million placement to Tribeca Investment Partners, confirming the transaction's material impact on its share price.
Maxwell Dee
Maxwell Dee
13 Nov 2025
Sagalio Energy’s shares surged sharply on November 12, prompting ASX to demand clarity on undisclosed information and compliance with disclosure rules.
Maxwell Dee
Maxwell Dee
12 Nov 2025
Mt Malcolm Mines NL has suspended trading of its M2MOA securities pending regulatory compliance, signaling a cautious pause for investors.
Maxwell Dee
Maxwell Dee
12 Nov 2025
Vectus Biosystems has responded to an ASX price query following a dramatic spike in its share price and trading volume, denying any undisclosed information and confirming compliance with ASX rules.
Ada Torres
Ada Torres
11 Nov 2025
Stealth Group Holdings has acquired Hardware & Building Traders for $22 million, creating Australia’s largest integrated hardware and industrial distribution platform and upgrading its FY28 financial outlook.
Victor Sage
Victor Sage
10 Nov 2025
Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.
Ada Torres
Ada Torres
7 Nov 2025
Finexia Financial Group Limited (ASX – FNX) has had its trading suspension lifted immediately following its public response to recent media speculation. The reinstatement marks a pivotal moment for the financial group’s market activity.
Claire Turing
Claire Turing
6 Nov 2025
James Hardie Industries faces intense scrutiny from the ASX after its share price dropped sharply and trading volumes spiked, prompting urgent questions about undisclosed information.
Victor Sage
Victor Sage
6 Nov 2025
Chimeric Therapeutics has responded to ASX inquiries regarding the disclosure timing and materiality of new clinical data from its ADVENT-AML trial, emphasizing compliance with continuous disclosure rules and the careful verification of promising patient responses.
Ada Torres
Ada Torres
6 Nov 2025
SportsHero Limited has voluntarily suspended trading on the ASX pending a Supreme Court decision regarding its failure to lodge required cleansing notices for recent share issues.
Sophie Babbage
Sophie Babbage
6 Nov 2025
ASF Group Limited has had its trading suspension lifted immediately following its responses to ASX queries, reopening its shares to market activity.
Victor Sage
Victor Sage
3 Nov 2025